A recent shift in the drug product environment for Africa has seen a score of new products being developed specifically for diseases of the developing world, creating new challenges for regulators in Africa and elsewhere.

The emotive row over universal flu vaccination misses a crucial fact – vaccines have a downside.

Encouraged by the early success of using dichloro-diphenyl-trichloroethane (DDT) against malaria, the World Health Organization (WHO) embarked on the Global Malaria Eradication Program (GMEP) in 1955.

The interruption of malaria transmission worldwide is one of the greatest challenges for international health and development communities.

Today's malaria control efforts are limited by our incomplete understanding of the biology of Plasmodium and of the complex relationships between human populations and the multiple species of mosquito and parasite. Research priorities include the development of in vitro culture systems for the complete life cycle of P. falciparum and P.

There is considerable international interest in exploiting the potential of digital solutions to enhance the quality and safety of health care. Implementations of transformative eHealth technologies are underway globally, often at
very considerable cost.

India rightly brands itself incredible. The country's remarkable political, economic, and cultural transformation over the past half century has made it a geopolitical force almost equal to that of China. The west has welcomed the growth of India: witness US President Barack Obama's recent support for Indian membership of the UN Security Council.

The debates around securing the right to health for all in India are at a complex and sensitive stage. In India, we have gross inequity in health-care delivery.

In India, despite improvements in access to health care, inequalities are related to socioeconomic status, geography, and gender, and are compounded by high out-of-pocket expenditures, with more than three-quarters of the increasing financial burden of health care being met by households.

Nearly 2 billion people (a third of the world's population) lack access to essential medicines. In low-income and middle-income countries, drugs account for 20